First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Files for Download
jiw493.pdf
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Voir les documents
Titre
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.
Sujet
Description
A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life.
Date
2017-01-15
Type
Citer ce document
Dörnemann, Jenny, Chiara Burzio, Axelle Ronsse, Armand Sprecher, Hilde De Clerck, Michel Van Herp, Marie-Claire Kolié, Vesselina Yosifiva, Severine Caluwaerts, Anita K. McElroy, and Annick Antierens. 2017. "First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease." The Journal of infectious diseases 215 (2):171-4.
Résumé
A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life. The patient was treated with monoclonal antibodies (ZMapp), a buffy coat transfusion from an Ebola survivor, and the broad-spectrum antiviral GS-5734. On day 20, a venous blood specimen tested negative for Ebola virus by quantitative reverse-transcription polymerase chain reaction. The patient was discharged in good health on day 33 of life. Further follow-up consultations showed age-appropriate weight gain and neurodevelopment at the age of 12 months. This patient is the first neonate documented to have survived congenital infection with Ebola virus.
Accessibilité
free on Pubmed
Was this resource helpful?